These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 28458172)

  • 1. Efficacy and toxicity of high-dose nebulized colistin for critically ill surgical patients with ventilator-associated pneumonia caused by multidrug-resistant Acinetobacter baumannii.
    Jang JY; Kwon HY; Choi EH; Lee WY; Shim H; Bae KS
    J Crit Care; 2017 Aug; 40():251-256. PubMed ID: 28458172
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of high-dose nebulized colistin in ventilator-associated pneumonia caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii.
    Lu Q; Luo R; Bodin L; Yang J; Zahr N; Aubry A; Golmard JL; Rouby JJ;
    Anesthesiology; 2012 Dec; 117(6):1335-47. PubMed ID: 23132092
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Nebulized colistin treatment of multi-resistant Acinetobacter baumannii pulmonary infection in critical ill patients].
    Pérez-Pedrero MJ; Sánchez-Casado M; Rodríguez-Villar S
    Med Intensiva; 2011 May; 35(4):226-31. PubMed ID: 21396739
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Use of high-dose IV and aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii ventilator-associated pneumonia: do we really need this treatment?
    Kalin G; Alp E; Coskun R; Demiraslan H; Gündogan K; Doganay M
    J Infect Chemother; 2012 Dec; 18(6):872-7. PubMed ID: 22644081
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Aerosolized colistin for the treatment of multidrug-resistant Acinetobacter baumannii pneumonia: experience in a tertiary care hospital in northern Taiwan.
    Lin CC; Liu TC; Kuo CF; Liu CP; Lee CM
    J Microbiol Immunol Infect; 2010 Aug; 43(4):323-31. PubMed ID: 20688293
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhaled colistin monotherapy for respiratory tract infections in adults without cystic fibrosis: a systematic review and meta-analysis.
    Vardakas KZ; Voulgaris GL; Samonis G; Falagas ME
    Int J Antimicrob Agents; 2018 Jan; 51(1):1-9. PubMed ID: 28669836
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Use of adjunctive aerosolized antimicrobial therapy in the treatment of Pseudomonas aeruginosa and Acinetobacter baumannii ventilator-associated pneumonia.
    Arnold HM; Sawyer AM; Kollef MH
    Respir Care; 2012 Aug; 57(8):1226-33. PubMed ID: 22349038
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Nebulized colistin in the treatment of pneumonia due to multidrug-resistant Acinetobacter baumannii and Pseudomonas aeruginosa.
    Kwa AL; Loh C; Low JG; Kurup A; Tam VH
    Clin Infect Dis; 2005 Sep; 41(5):754-7. PubMed ID: 16080101
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of loading dose of colistin in Acinetobacter baumannii ventilator-associated pneumonia.
    Alp E; Eren E; Elay G; Cevahir F; Esmaoğlu A; Rello J
    Infez Med; 2017 Dec; 25(4):311-319. PubMed ID: 29286009
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Impact of colistin-initiation delay on mortality of ventilator-associated pneumonia caused by A. baumannii.
    Samrah S; Bashtawi Y; Hayajneh W; Almomani B; Momany S; Khader Y
    J Infect Dev Ctries; 2016 Oct; 10(10):1129-1134. PubMed ID: 27801377
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Colistin-based treatment for extensively drug-resistant Acinetobacter baumannii pneumonia.
    Khawcharoenporn T; Pruetpongpun N; Tiamsak P; Rutchanawech S; Mundy LM; Apisarnthanarak A
    Int J Antimicrob Agents; 2014 Apr; 43(4):378-82. PubMed ID: 24613422
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Colistin alone or combined with sulbactam or carbapenem against A. baumannii in ventilator-associated pneumonia.
    Yilmaz GR; Guven T; Guner R; Kocak Tufan Z; Izdes S; Tasyaran MA; Acikgoz ZC
    J Infect Dev Ctries; 2015 May; 9(5):476-85. PubMed ID: 25989167
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of colistin and colistin/sulbactam for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Kalin G; Alp E; Akin A; Coskun R; Doganay M
    Infection; 2014 Feb; 42(1):37-42. PubMed ID: 23828559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy and safety of colistin (colistimethate sodium) for therapy of infections caused by multidrug-resistant Pseudomonas aeruginosa and Acinetobacter baumannii in Siriraj Hospital, Bangkok, Thailand.
    Koomanachai P; Tiengrim S; Kiratisin P; Thamlikitkul V
    Int J Infect Dis; 2007 Sep; 11(5):402-6. PubMed ID: 17291803
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Is inhaled colistin beneficial in ventilator associated pneumonia or nosocomial pneumonia caused by Acinetobacter baumannii?
    Demirdal T; Sari US; Nemli SA
    Ann Clin Microbiol Antimicrob; 2016 Feb; 15():11. PubMed ID: 26911714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy and safety of high-dose ampicillin/sulbactam vs. colistin as monotherapy for the treatment of multidrug resistant Acinetobacter baumannii ventilator-associated pneumonia.
    Betrosian AP; Frantzeskaki F; Xanthaki A; Douzinas EE
    J Infect; 2008 Jun; 56(6):432-6. PubMed ID: 18501431
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical and in vitro efficacy of colistin plus vancomycin and rifampin against colistin-resistant Acinetobacter baumannii causing ventilator-associated pneumonia.
    Oliva A; Cipolla A; Vullo V; Venditti M; Mastroianni CM; Falcone M
    New Microbiol; 2017 Jul; 40(3):205-207. PubMed ID: 28675246
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Colistin use in ventilator-associated pneumonia due to panresistant Pseudomonas aeruginosa and Acinetobacter baumannii].
    Taşbakan MS; Pullukçu H; Ekren PK; Oz AT; Midilli M; Aydemir S; Gürgün A; Başoğlu OK; Bacakoğlu F
    Mikrobiyol Bul; 2009 Jan; 43(1):61-70. PubMed ID: 19334381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparable Efficacy of Tigecycline versus Colistin Therapy for Multidrug-Resistant and Extensively Drug-Resistant Acinetobacter baumannii Pneumonia in Critically Ill Patients.
    Kim WY; Moon JY; Huh JW; Choi SH; Lim CM; Koh Y; Chong YP; Hong SB
    PLoS One; 2016; 11(3):e0150642. PubMed ID: 26934182
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differences in pharmacokinetics and pharmacodynamics of colistimethate sodium (CMS) and colistin between three different CMS dosage regimens in a critically ill patient infected by a multidrug-resistant Acinetobacter baumannii.
    Luque S; Grau S; Valle M; Sorlí L; Horcajada JP; Segura C; Alvarez-Lerma F
    Int J Antimicrob Agents; 2013 Aug; 42(2):178-81. PubMed ID: 23769664
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.